147 related articles for article (PubMed ID: 8761336)
1. Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients.
Gibson G; Martins R; Blass J; Gandy S
Life Sci; 1996; 59(5-6):477-89. PubMed ID: 8761336
[TBL] [Abstract][Full Text] [Related]
2. Use of cultured fibroblasts in elucidating the pathophysiology and diagnosis of Alzheimer's disease.
Huang HM; Martins R; Gandy S; Etcheberrigaray R; Ito E; Alkon DL; Blass J; Gibson G
Ann N Y Acad Sci; 1994 Dec; 747():225-44. PubMed ID: 7847673
[No Abstract] [Full Text] [Related]
3. Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation.
Gibson GE; Vestling M; Zhang H; Szolosi S; Alkon D; Lannfelt L; Gandy S; Cowburn RF
Neurobiol Aging; 1997; 18(6):573-80. PubMed ID: 9461055
[TBL] [Abstract][Full Text] [Related]
4. Peripheral cells as an investigational tool for Alzheimer's disease.
Govoni S; Gasparini L; Racchi M; Trabucchi M
Life Sci; 1996; 59(5-6):461-8. PubMed ID: 8761334
[TBL] [Abstract][Full Text] [Related]
5. Lymphocytes and neutrophils as peripheral models to study the effect of beta-amyloid on cellular calcium signalling in Alzheimer's disease.
Eckert A; Förstl H; Zerfass R; Hartmann H; Müller WE
Life Sci; 1996; 59(5-6):499-510. PubMed ID: 8761338
[TBL] [Abstract][Full Text] [Related]
6. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.
Citron M; Vigo-Pelfrey C; Teplow DB; Miller C; Schenk D; Johnston J; Winblad B; Venizelos N; Lannfelt L; Selkoe DJ
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):11993-7. PubMed ID: 7991571
[TBL] [Abstract][Full Text] [Related]
7. Cell-cycle-dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease.
Tatebayashi Y; Takeda M; Kashiwagi Y; Okochi M; Kurumadani T; Sekiyama A; Kanayama G; Hariguchi S; Nishimura T
Dementia; 1995; 6(1):9-16. PubMed ID: 7728221
[TBL] [Abstract][Full Text] [Related]
8. Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.
Duncan RS; Song B; Koulen P
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857474
[TBL] [Abstract][Full Text] [Related]
9. Presenilins as endoplasmic reticulum calcium leak channels and Alzheimer's disease pathogenesis.
Supnet C; Bezprozvanny I
Sci China Life Sci; 2011 Aug; 54(8):744-51. PubMed ID: 21786197
[TBL] [Abstract][Full Text] [Related]
10. Fibroblasts and lymphocytes from Alzheimer patients are resistant to beta-amyloid-induced increase in the intracellular calcium concentration.
Palotás A; Kálmán J; Palotás M; Juhász A; Janka Z; Penke B
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):971-4. PubMed ID: 12369273
[TBL] [Abstract][Full Text] [Related]
11. Soluble beta-amyloid induces Alzheimer's disease features in human fibroblasts and in neuronal tissues.
Etcheberrigaray R; Payne JL; Alkon DL
Life Sci; 1996; 59(5-6):491-8. PubMed ID: 8761337
[TBL] [Abstract][Full Text] [Related]
12. Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease.
Gibson GE
Free Radic Biol Med; 2002 Jun; 32(11):1061-70. PubMed ID: 12031890
[TBL] [Abstract][Full Text] [Related]
13. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
[TBL] [Abstract][Full Text] [Related]
14. Alterations of intracellular calcium regulation during aging and Alzheimer's disease in nonneuronal cells.
Eckert A; Hartmann H; Förstl H; Müller WE
Life Sci; 1994; 55(25-26):2019-29. PubMed ID: 7997061
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
Mattson MP; Chan SL
J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
[TBL] [Abstract][Full Text] [Related]
16. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease.
Gasparini L; Racchi M; Binetti G; Trabucchi M; Solerte SB; Alkon D; Etcheberrigaray R; Gibson G; Blass J; Paoletti R; Govoni S
FASEB J; 1998 Jan; 12(1):17-34. PubMed ID: 9438407
[TBL] [Abstract][Full Text] [Related]
17. Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities.
Pascale A; Etcheberrigaray R
Pharmacol Res; 1999 Feb; 39(2):81-8. PubMed ID: 10072697
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
Gandy S; Petanceska S
Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
[TBL] [Abstract][Full Text] [Related]
19. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
